Dolomite, part of the Blacktrace group of companies, is celebrating a decade of excellence in the design and manufacture of novel, high quality microfluidic products, including individual components such as pumps, chips, connectors, temperature controllers and sensors, software solutions and complete microfluidic systems.
The company, based in Royston, UK, was the world’s first microfluidic application centre, and has gone from strength to strength since its formation in 2005, opening offices in the USA, Japan, India and Brazil, and establishing a global distributor network. Today, it serves many thousands of customers in over 50 countries around the world, working in fields as diverse as academia, biotechnology, drug discovery, food and cosmetics...
LUSH Cosmetics Awards Group £25,000 for Its Educational and Training Work
The PETA International Science Consortium Ltd. will receive the prestigious LUSH Prize Training Award in London today. The award recognises the Science Consortium's multifaceted approach to providing educational outreach to companies and regulators through the organisation of webinars, initiating face-to-face training sessions, and developing educational resources to promote the acceptance and uptake of non-animal methods...
UK-based drug discovery services provider Peakdale Molecular (part of the Concept Life Sciences Group) has strengthened its sales and marketing team through the addition of a Head of Sales and Marketing.
Gordon Woodrow, BSc in Applied Microbiology, has been appointed Head of Sales and Marketing and joins Peakdale with over 25 years of commercial experience having held a number of senior positions in companies offering scientific services to the pharmaceutical and biotech industries. Prior to joining Peakdale Gordon was responsible for business development and strategic alliances at Proteros Biostructures. Whilst there Gordon played...
Trajan Scientific and Medical (Trajan) has announced the opening of a new Business Unit - Instruments, Sensors and Devices, to be located at the University of Adelaide’s Institute for Photonics and Advanced Sensing (IPAS).
Along with the new capabilities existing on that site such as glass modification and extrusion, the new Business Unit will have global responsibilities for new devices such as the recently revealed hemaPEN™ for dried blood spot sampling. This announcement comes just two months after Trajan’s landmark strategic collaboration with the University of Adelaide, supported by the South Australian Government, was revealed...
Agreement initially focuses on generation of gene edited induced pluripotent stem cells (iPSCs) for use in neuronal and cardiovascular disease research and brings together Horizon’s precision genome editing capability and Axol’s expertise in iPSC differentiation
Horizon Discovery Group plc (LSE:HZD) (Horizon), the international life science company supplying research tools and services to organizations engaged in genomics research and the development of personalized medicines, and Axol Bioscience Ltd (Axol), a biotechnology company specializing in the use of stem cell technology to manufacture disease relevant cell based assay systems, announce they have formed a strategic partnership...
To cope with an ever increasing demand for 24-hour turnaround of sample data, Warwick Analytical Service has invested in an additional state-of-the-art ICP spectrophotometer for its Coventry, UK facility.
Operating in an ISO 17025 and GMP compliant environment following strict operating procedures ensures Warwick Analytical Service (WAS) delivers top quality ICP data consistently. Equipped with several modern high resolution ICP-OES instruments and microwave digestion equipment - Warwick Analytical Service is able to offer its ICP analytical sample services on a wide range of sample types. Tracie Hart, Laboratory Manager at...
Bulk production facility enables company to support large diagnostics customers
Innova Biosciences (Innova), a specialist provider of bioconjugation products and services, today announced the installation of bulk production capability for its colloidal gold nanoparticle products. The move enables the company to support any scale of operation, including the largest players in the diagnostics field. Innova’s ultra-high quality colloidal gold nanoparticles have a consistent uniform shape and size, ensuring reliability and...
The work of scientists and campaigners from around the world to end animal testing is being celebrated in a special issue of FRAME’s peer-reviewed journal ATLA (Alternatives to Laboratory Animals) Journal.
Produced each year in collaboration with the Lush Prize, the largest annual prize fund rewarding initiatives to end animal testing for toxicology research, the special issue of ATLA is a reflective look at the work of last year’s Lush Prize winners. Copies will be distributed at the awards dinner later this week. Included in the journal, are the winners of the 2014 Lush Prize for Science, Professor Grafström, and Dr Kohonen from Sweden’s Karolinska...
LGC, the international life sciences and measurement company, today announces that it has acquired Maine Standards Company, the leading provider of calibration verification materials for clinical laboratories in the US.
The acquisition bolsters LGC’s growing portfolio of reference materials and proficiency testing (PT) schemes for the clinical market. Euan O’Sullivan, Managing Director of LGC’s Standards Division, said, “We are delighted to welcome Maine Standards Company to LGC. Our two organisations represent a highly complementary commercial and cultural fit, with a common commitment to developing products of the very highest quality for the benefit of...
The inaugural Diabetes Professional Care (DPC) 2015 conference and exhibition was a major success.
Clinical scientists right through to pharmacists flocked to the Barbican Exhibition Centre to see how the new event – the UK’s only free-to-attend CPD accredited – would shape up. The overwhelming consensus was that it worked brilliantly and has plugged a major hole in the UK diabetes market. Punya Liyanage, Health Economy Liaison Manager – Diabetes – Janssen, visiting the show, enthused: “Fantastic to have a free-to-attend...
The European Commission has signed the grant agreement for the latest phase of the GÉANT project, GN4-1, which runs to April 2016 with a funding level of €25m.
"I am delighted to announce the signature of the new grant agreement between GÉANT and the EC. With this signature, we will reinforce even further our pan-European network for scientific excellence and European research and innovation. By assuring world-leading connectivity between Europe and the rest of the world in support of global research collaborations, GÉANT continues to help researchers and the wider community to...
The funds will be used to fuel international growth and to enter into the in-vitro diagnostics market.
Ovizio Imaging Systems, an innovative Belgian company developing cell counting solutions based on quantitative microscopy for life sciences applications, today announces it has secured a funding round of €8m ($9.1m) co-led by New Science Ventures, a US-based venture capital firm, and a private investor. This funding round...
The Cell Therapy Catapult, the UK organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, today announces the official initiation of construction for its cell and gene therapy manufacturing centre. John Brown marked the beginning of construction at an event on the site. Marking the importance of the manufacturing centre to the international cell...
Beckman Coulter Life Sciences and IncellDx, Inc. announced today they have signed a distribution agreement which focuses exclusively on clinical researchers in China, Hong Kong and Taiwan working on the Human Papilloma Virus (HPV) and cancer.
The commercial partnership brings the power of multi-parameter flow cytometry to molecular testing, improving workflow while delivering sensitive and highly reliable cell identification. IncellDx’s next generation (3Dx) investigational molecular assay used to quantify HPV E6, E7 mRNA in single cells has been specially optimized to run on Beckman Coulter’s innovative CytoFLEX flow cytometry system.* The high throughput system instrument...
Visitors at the SLAS in San Diego will witness the international premiere of the new reference multi-mode HTS reader PHERAstar® FSX.
The latest evolution in microplate reader instrumentation combines the best sensitivity on the market, highest speed and unmatched flexibility in plate formats up to 3456 wells. Visit booth #915 from January 23rd-27th to see German engineering at its best. The ultimate microplate reader for HTS applications. Built upon the successful PHERAstar® FS platform, the PHERAstar® FSX has improved features that make it superior...
Lab Innovations 2015, the UK’s only event dedicated to laboratory equipment, technology and services, saw a record-breaking number of visitors through its doors, with over 2,000 in attendance.
The event, which took place at Birmingham’s NEC on 4 & 5 November, witnessed the UK’s largest collection of science and laboratory innovation under one roof. Daniel Gray, Lab Innovations Event Manager comments: “The attendance figures for this year’s show have exceeded our expectations. The show has once again proven that it is the go-to event for all lab professionals. This year more than ever we saw the show bring together the...
Laboratory Information Management Systems (LIMS) specialist, Autoscribe Informatics, has published a new case study describing the use of the Matrix Gemini LIMS in a major Radiological, Environmental and Analytical Laboratory.
The laboratory carries out radioanalytical analysis of environmental samples to provide support for characterisation and independent verification surveys. A LIMS was needed to replace its in-house relational database which could no longer be supported. The system was required to handle a large volume of data and perform unique calculations to correct results. In order to facilitate this, ‘custom table mapping’, a standard technology...
Antibiotic Research UK (ANTRUK), a charity founded in 2014 to save modern medicine from the onslaught of superbugs, is delighted to announce that the Most Reverend & Right Honourable Dr John Sentamu, Archbishop of York has agreed to become the Charity’s Patron.
Superbugs are fast becoming an increasing problem in hospitals and the community as bacteria become increasingly resistant to our existing antibiotics. There is a significant risk that future generations will not enjoy the same benefits of medicine as we do today. All the medical procedures currently taken for granted, for example cancer treatment, open heart surgery, hip and knee replacement and organ transplantation will become much more perilous...
Proprietary technology allows superior LOH detection in challenging samples
Oxford Gene Technology (OGT), The Molecular Genetics Company, has entered into a deal with Baylor Miraca Genetics Laboratories (BMGL), licensing the use of OGT’s proprietary single nucleotide polymorphism (SNP) array probe technology. This novel technology overcomes the limitations of restriction enzyme-based SNP probe approaches previously employed at BMGL for loss of heterozygosity (LOH) detection, allowing accurate array-based analysis of low...
Protagen AG,a leading specialist in the development of novel diagnostic tests and companion diagnostics in the autoimmune field, and Mikrogen GmbH, the European market leader in Lyme disease diagnostics, agreed on a co-development program for a new diagnostic assay to distinguish between previously infected, seropositive individuals, from newly infected patients with active Lyme disease.
The agreement builds on a previous research collaboration between both companies and the results obtained using the proprietary SeroTag® technology developed by Protagen. "Finding potential diagnostic biomarkers indicative of Lyme disease activity would be a breakthrough for diagnostics and therapy," explains Dr. Erwin Soutschek, founder and CEO of Mikrogen. "Employing the technology of Protagen, we have identified a...
Novasep’s BioSC® Lab continuous biochromatography equipment will enable CPI to disseminate next-generation downstream processes
Novasep, a leading supplier of services and technologies for the life sciences industry, and the Centre for Process Innovation (CPI), a UK-based technology innovation centre, today announce they have equipped the UK National Biologics Manufacturing Centre with BioSC Lab, the latest state-of-the art technology for protein purification. According to The Future of High Value Manufacturing in the UK report (published by the Knowledge...
Xylem Inc. (NYSE: XYL), a leading global water technology company dedicated to solving the world’s most challenging water issues, has acquired HYPACK, Inc. a privately-owned company specializing in hydrographic survey software used in ocean, coastal and surface water applications, for approximately $18 million.
News of acquisition was shared in the Company’s third quarter earnings announcement. Other terms of the transaction were not disclosed. Located in Middletown, Connecticut, HYPACK is a leading provider of hydrographic survey data acquisition, processing, and visualization software. Used by government agencies, universities, and consultants, HYPACK products measure and map features in bodies of water in connection with maritime...
The company, based in Royston, UK, was the world’s first microfluidic application centre, and has gone from strength to strength since its formation in 2005, opening offices in the USA, Japan, India and Brazil, and establishing a global distributor network. Today, it serves many thousands of customers in over 50 countries around the world, working in fields as diverse as academia, biotechnology, drug discovery, food and cosmetics...
The PETA International Science Consortium Ltd. will receive the prestigious LUSH Prize Training Award in London today. 
Gordon Woodrow
Along with the new capabilities existing on that site such as glass modification and extrusion, the new Business Unit will have global responsibilities for new devices such as the recently revealed hemaPEN™ for dried blood spot sampling. 
Horizon Discovery Group plc (LSE:HZD) (Horizon), the international life science company supplying research tools and services to organizations engaged in genomics research and the development of personalized medicines, and Axol Bioscience Ltd (Axol), a biotechnology company specializing in the use of stem cell technology to manufacture disease relevant cell based assay systems, announce they have formed a strategic partnership...
Operating in an ISO 17025 and GMP compliant environment following strict operating procedures ensures Warwick Analytical Service (WAS) delivers top quality ICP data consistently. Equipped with several modern high resolution ICP-OES instruments and microwave digestion equipment - Warwick Analytical Service is able to offer its ICP analytical sample services on a wide range of sample types. 
Innova Biosciences (Innova), a specialist provider of bioconjugation products and services, today announced the installation of bulk production capability for its colloidal gold nanoparticle products. The move enables the company to support any scale of operation, including the largest players in the diagnostics field. 
Produced each year in collaboration with the Lush Prize, the largest annual prize fund rewarding initiatives to end animal testing for toxicology research, the special issue of ATLA is a reflective look at the work of last year’s Lush Prize winners. Copies will be distributed at the awards dinner later this week. 
The acquisition bolsters LGC’s growing portfolio of reference materials and proficiency testing (PT) schemes for the clinical market. Euan O’Sullivan, Managing Director of LGC’s Standards Division, said, “We are delighted to welcome Maine Standards Company to LGC. Our two organisations represent a highly complementary commercial and cultural fit, with a common commitment to developing products of the very highest quality for the benefit of...
Clinical scientists right through to pharmacists flocked to the Barbican Exhibition Centre to see how the new event – the UK’s only free-to-attend CPD accredited – would shape up. The overwhelming consensus was that it worked brilliantly and has plugged a major hole in the UK diabetes market. 
"I am delighted to announce the signature of the new grant agreement between GÉANT and the EC. With this signature, we will reinforce even further our pan-European network for scientific excellence and European research and innovation. By assuring world-leading connectivity between Europe and the rest of the world in support of global research collaborations, GÉANT continues to help researchers and the wider community to...
Ovizio Imaging Systems, an innovative Belgian company developing cell counting solutions based on quantitative microscopy for life sciences applications, today announces it has secured a funding round of €8m ($9.1m) co-led by New Science Ventures, a US-based venture capital firm, and a private investor. This funding round...
The Cell Therapy Catapult, the UK organisation dedicated to the growth of the UK cell and gene therapy industry by bridging the gap between scientific research and commercialisation, today announces the official initiation of construction for its cell and gene therapy manufacturing centre. 
The commercial partnership brings the power of multi-parameter flow cytometry to molecular testing, improving workflow while delivering sensitive and highly reliable cell identification. 
The latest evolution in microplate reader instrumentation combines the best sensitivity on the market, highest speed and unmatched flexibility in plate formats up to 3456 wells. Visit booth #915 from January 23
The event, which took place at Birmingham’s NEC on 4 & 5 November, witnessed the UK’s largest collection of science and laboratory innovation under one roof. 
The laboratory carries out radioanalytical analysis of environmental samples to provide support for characterisation and independent verification surveys. A LIMS was needed to replace its in-house relational database which could no longer be supported. 
Superbugs are fast becoming an increasing problem in hospitals and the community as bacteria become increasingly resistant to our existing antibiotics. There is a significant risk that future generations will not enjoy the same benefits of medicine as we do today. All the medical procedures currently taken for granted, for example cancer treatment, open heart surgery, hip and knee replacement and organ transplantation will become much more perilous...
Oxford Gene Technology
The agreement builds on a previous research collaboration between both companies and the results obtained using the proprietary SeroTag
Novasep, a leading supplier of services and technologies for the life sciences industry, and the Centre for Process Innovation (CPI), a UK-based technology innovation centre, today announce they have equipped the UK National Biologics Manufacturing Centre with BioSC Lab, the latest state-of-the art technology for protein purification. According to The Future of High Value Manufacturing in the UK report (published by the Knowledge...
News of acquisition was shared in the Company’s third quarter earnings announcement. Other terms of the transaction were not disclosed.